Cargando…

Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China

PURPOSE: This study aimed to develop two predictive nomograms for the assessment of long-term survival status in hemodialysis (HD) patients by examining the prognostic factors for all-cause mortality and cardiovascular (CVD) event mortality. PATIENTS AND METHODS: A total of 551 HD patients with an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Min, Yang, Yaqin, Xu, Yuntong, Wu, Yuchi, Lin, Jiarong, Mai, Jianling, Fang, Kunyang, Ma, Xiangxia, Zou, Chuan, Lin, Qizhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392814/
https://www.ncbi.nlm.nih.gov/pubmed/37534232
http://dx.doi.org/10.2147/CIA.S416421
_version_ 1785083030483763200
author Yang, Min
Yang, Yaqin
Xu, Yuntong
Wu, Yuchi
Lin, Jiarong
Mai, Jianling
Fang, Kunyang
Ma, Xiangxia
Zou, Chuan
Lin, Qizhan
author_facet Yang, Min
Yang, Yaqin
Xu, Yuntong
Wu, Yuchi
Lin, Jiarong
Mai, Jianling
Fang, Kunyang
Ma, Xiangxia
Zou, Chuan
Lin, Qizhan
author_sort Yang, Min
collection PubMed
description PURPOSE: This study aimed to develop two predictive nomograms for the assessment of long-term survival status in hemodialysis (HD) patients by examining the prognostic factors for all-cause mortality and cardiovascular (CVD) event mortality. PATIENTS AND METHODS: A total of 551 HD patients with an average age of over 60 were included in this study. The patients’ medical records were collected from our hospital and randomly allocated to two cohorts: the training cohort (n=385) and the validation cohort (n=166). We employed multivariate Cox assessments and fine-gray proportional hazards models to explore the predictive factors for both all-cause mortality and cardiovascular event mortality risk in HD patients. Two nomograms were established based on predictive factors to forecast patients’ likelihood of survival for 3, 5, and 8 years. The performance of both models was evaluated using the area under the curve (AUC), calibration plots, and decision curve analysis. RESULTS: The nomogram for all-cause mortality prediction included seven factors: age ≥ 60, sex (male), history of diabetes and coronary artery disease, diastolic blood pressure, total triglycerides (TG), and total cholesterol (TC). The nomogram for cardiovascular event mortality prediction included three factors: history of diabetes and coronary artery disease, and total cholesterol (TC). Both models demonstrated good discrimination, with AUC values of 0.716, 0.722 and 0.725 for all-cause mortality at 3, 5, and 8 years, respectively, and 0.702, 0.695, and 0.677 for cardiovascular event mortality, respectively. The calibration plots indicated a good agreement between the predictions and the decision curve analysis demonstrated a favorable clinical utility of the nomograms. CONCLUSION: Our nomograms were well-calibrated and exhibited significant estimation efficiency, providing a valuable predictive tool to forecast prognosis in HD patients.
format Online
Article
Text
id pubmed-10392814
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103928142023-08-02 Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China Yang, Min Yang, Yaqin Xu, Yuntong Wu, Yuchi Lin, Jiarong Mai, Jianling Fang, Kunyang Ma, Xiangxia Zou, Chuan Lin, Qizhan Clin Interv Aging Original Research PURPOSE: This study aimed to develop two predictive nomograms for the assessment of long-term survival status in hemodialysis (HD) patients by examining the prognostic factors for all-cause mortality and cardiovascular (CVD) event mortality. PATIENTS AND METHODS: A total of 551 HD patients with an average age of over 60 were included in this study. The patients’ medical records were collected from our hospital and randomly allocated to two cohorts: the training cohort (n=385) and the validation cohort (n=166). We employed multivariate Cox assessments and fine-gray proportional hazards models to explore the predictive factors for both all-cause mortality and cardiovascular event mortality risk in HD patients. Two nomograms were established based on predictive factors to forecast patients’ likelihood of survival for 3, 5, and 8 years. The performance of both models was evaluated using the area under the curve (AUC), calibration plots, and decision curve analysis. RESULTS: The nomogram for all-cause mortality prediction included seven factors: age ≥ 60, sex (male), history of diabetes and coronary artery disease, diastolic blood pressure, total triglycerides (TG), and total cholesterol (TC). The nomogram for cardiovascular event mortality prediction included three factors: history of diabetes and coronary artery disease, and total cholesterol (TC). Both models demonstrated good discrimination, with AUC values of 0.716, 0.722 and 0.725 for all-cause mortality at 3, 5, and 8 years, respectively, and 0.702, 0.695, and 0.677 for cardiovascular event mortality, respectively. The calibration plots indicated a good agreement between the predictions and the decision curve analysis demonstrated a favorable clinical utility of the nomograms. CONCLUSION: Our nomograms were well-calibrated and exhibited significant estimation efficiency, providing a valuable predictive tool to forecast prognosis in HD patients. Dove 2023-07-28 /pmc/articles/PMC10392814/ /pubmed/37534232 http://dx.doi.org/10.2147/CIA.S416421 Text en © 2023 Yang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yang, Min
Yang, Yaqin
Xu, Yuntong
Wu, Yuchi
Lin, Jiarong
Mai, Jianling
Fang, Kunyang
Ma, Xiangxia
Zou, Chuan
Lin, Qizhan
Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China
title Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China
title_full Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China
title_fullStr Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China
title_full_unstemmed Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China
title_short Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China
title_sort development and validation of prediction models for all-cause mortality and cardiovascular mortality in patients on hemodialysis: a retrospective cohort study in china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392814/
https://www.ncbi.nlm.nih.gov/pubmed/37534232
http://dx.doi.org/10.2147/CIA.S416421
work_keys_str_mv AT yangmin developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina
AT yangyaqin developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina
AT xuyuntong developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina
AT wuyuchi developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina
AT linjiarong developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina
AT maijianling developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina
AT fangkunyang developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina
AT maxiangxia developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina
AT zouchuan developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina
AT linqizhan developmentandvalidationofpredictionmodelsforallcausemortalityandcardiovascularmortalityinpatientsonhemodialysisaretrospectivecohortstudyinchina